FDA announces Class 1 recall for implantable ports
Editor's Note
The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death.
The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the agency’s March 19 announcement, the recall was motivated by a manufacturing defect that may cause the plastic port housing and port reservoir to separate before, during, or after implantation. Two injuries and zero deaths have been reported.
Patients with an implanted device should be monitored for adverse events, and the housing and reservoir should feel secure and stable when palpating the portal, the agency advises. Customers and distributors should stop use and quarantine any inventory.
Free Daily News
- FDA issues Class I alert for Abiomed Impella heart device over cybersecurity risks
- Study finds Medicare paid nearly $2 billion for unnecessary back surgeries
- FDA accelerates medical device safety alerts to reach public within days
- California’s worsening nurse shortage fuels burnout, safety concerns amid management tensions
- AI is turning medical devices into learning systems, Google Cloud exec says
- Tray-based setups cut OR waste, setup time while boosting workflow satisfaction
- OR Manager Conference delivers ready-to-use solutions for perioperative leaders
- The Joint Commission set to spotlight hospitals’ strengths with new SAFEST initiative
- FDA has begun requiring electronic De Novo submissions for new medical devices
- Spine surgeon shortage deepens as consolidation, site shifts reshape ASC markets